Investigating differential dynamics of the MAPK signaling cascade using a multi-parametric global sensitivity analysis

PLoS ONE

Volumn 4, Issue 2, 2009, Pages

  Yoon, Jeongah ^a   Deisboeck, Thomas S ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; RAF PROTEIN; RAS PROTEIN;

ARTICLE; CELL FATE; CHEMICAL REACTION KINETICS; COMPUTER ANALYSIS; COMPUTER SIMULATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME INACTIVATION; MICHAELIS MENTEN KINETICS; MOLECULAR DYNAMICS; MONTE CARLO METHOD; PHOSPHORYLATION AND DEPHOSPHORYLATION; PROTEIN ANALYSIS; PROTEIN FUNCTION; REGULATORY MECHANISM; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION;

EID: 84887212461     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004560     Document Type: Article

References (37)

1. Blume-Jensen P, Hunter T (2001) Oncogenic kinase signalling. Nature 411: 355-365.
2. Schlessinger J (2004) Common and distinct elements in cellular signaling via EGF and FGF receptors. Science 306: 1506-1507.
3. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S (2002) The protein kinase complement of the human genome. Science 298: 1912-1934.
4. Lewis TS, Shapiro PS, Ahn NG (1998) Signal transduction through MAP kinase cascades. Advances in cancer research 74: 49-139.
5. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100: 57-70.
6. Marshall CJ (1995) Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80: 179-185.
7. Cook SJ, Aziz N, McMahon M (1999) The repertoire of fos and jun proteins expressed during the G1 phase of the cell cycle is determined by the duration of mitogen-activated protein kinase activation. Mol Cell Biol 19: 330-341.
8. Tombes RM, Auer KL, Mikkelsen R, Valerie K, Wymann MP, et al. (1998) The mitogen-activated protein (MAP) kinase cascade can either stimulate or inhibit DNA synthesis in primary cultures of rat hepatocytes depending upon whether its activation is acute/phasic or chronic. Biochem J 330 (Pt 3): 1451-1460.
9. Traverse S, Gomez N, Paterson H, Marshall C, Cohen P (1992) Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor. Biochem J 288 (Pt 2): 351-355.
10. Sasagawa S, Ozaki Y, Fujita K, Kuroda S (2005) Prediction and validation of the distinct dynamics of transient and sustained ERK activation. Nat Cell Biol 7: 365-373.
11. Yaka R, Gamliel A, Gurwitz D, Stein R (1998) NGF induces transient but not sustained activation of ERK in PC12 mutant cells incapable of differentiating. J Cell Biochem 70: 425-432.
12. Sebolt-Leopold JS (2000) Development of anticancer drugs targeting the MAP kinase pathway. Oncogene 19: 6594-6599.
13. Snoep JL (2005) The Silicon Cell initiative: working towards a detailed kinetic description at the cellular level. Curr Opin Biotechnol 16: 336-343.
14. Kitano H (2002) Computational systems biology. Nature 420: 206-210.
15. Brightman FA, Fell DA (2000) Differential feedback regulation of the MAPK cascade underlies the quantitative differences in EGF and NGF signalling in PC12 cells. FEBS Lett 482: 169-174.
16. Hornberg JJ, Binder B, Bruggeman FJ, Schoeberl B, Heinrich R, et al. (2005) Control of MAPK signalling: from complexity to what really matters. Oncogene 24: 5533-5542.
17. Ebisuya M, Kondoh K, Nishida E (2005) The duration, magnitude and compartmentalization of ERK MAP kinase activity: mechanisms for providing signaling specificity. J Cell Sci 118: 2997-3002.
18. Asthagiri AR, Lauffenburger DA (2001) A computational study of feedback effects on signal dynamics in a mitogen-activated protein kinase (MAPK) pathway model. Biotechnol Prog 17: 227-239.
19. Bhalla US, Ram PT, Iyengar R (2002) MAP kinase phosphatase as a locus of flexibility in a mitogen-activated protein kinase signaling network. Science 297: 1018-1023.
20. Markevich NI, Tsyganov MA, Hoek JB, Kholodenko BN (2006) Long-range signaling by phosphoprotein waves arising from bistability in protein kinase cascades. Mol Syst Biol 2: 61.
21. Smolen P, Baxter DA, Byrne JH (2008) Bistable MAP kinase activity: a plausible mechanism contributing to maintenance of late long-term potentiation. Am J Physiol Cell Physiol 294: C503-515.
22. Ferrell JE Jr (2002) Self-perpetuating states in signal transduction: positive feedback, double-negative feedback and bistability. Curr Opin Cell Biol 14: 140-148.
23. Bhalla US, Iyengar R (1999) Emergent properties of networks of biological signaling pathways. Science 283: 381-387.
24. Fujioka A, Terai K, Itoh RE, Aoki K, Nakamura T, et al. (2006) Dynamics of the Ras/ERK MAPK cascade as monitored by fluorescent probes. J Biol Chem 281: 8917-8926.
25. Cho KH, Shin SY, Kolch W, Wolkenhauer O (2003) Experimental Design in Systems Biology, Based on Parameter Sensitivity Analysis Using a Monte Carlo Method: A Case Study for the TNF{alpha}-Mediated NF-{kappa} B Signal Transduction Pathway. SIMULATION: Transactions of The Society for Modeling and Simulation International 79: 726-739.
26. Saltelli A, Tarantola S, Campolongo F, M. R (2004) Sensitivity Analysis in Practice: A Guide to Assessing Scientific Models John Wiley & Sons, Ltd. 232 p.
27. Brightman FA (2001) Computer Simulation of a Growth Factor Signal Transduction Pathway. Oxford Brookes University.
28. Stelling J, Gilles ED, Doyle FJ 3rd (2004) Robustness properties of circadian clock architectures. Proc Natl Acad Sci U S A 101: 13210-13215.
29. Savageau MA (1971) Parameter sensitivity as a criterion for evaluating and comparing the performance of biochemical systems. Nature 229: 542-544.
30. Cox AD, Der CJ (2002) Ras family signaling: therapeutic targeting. Cancer Biol Ther 1: 599-606.
31. Reuter CW, Morgan MA, Bergmann L (2000) Targeting the Ras signaling pathway: a rational, mechanism-based treatment for hematologic malignancies? Blood 96: 1655-1669.
32. Adachi T, Kar S, Wang M, Carr BI (2002) Transient and sustained ERK phosphorylation and nuclear translocation in growth control. J Cell Physiol 192: 151-159.
33. Hornberg JJ, Bruggeman FJ, Binder B, Geest CR, de Vaate AJ, et al. (2005) Principles behind the multifarious control of signal transduction. ERK phosphorylation and kinase/phosphatase control. Febs J 272: 244-258.
34. Birtwistle MR, Hatakeyama M, Yumoto N, Ogunnaike BA, Hoek JB, et al. (2007) Ligand-dependent responses of the ErbB signaling network: experimental and modeling analyses. Mol Syst Biol 3: 144.
35. Cantley LC (2002) The phosphoinositide 3-kinase pathway. Science 296: 1655-1657.
36. Bonabeau E (2002) Agent-based modeling: methods and techniques for simulating human systems. Proc Natl Acad Sci U S A 99 Suppl 3: 7280-7287.
37. Zhang L, Athale CA, Deisboeck TS (2007) Development of a three-dimensional multiscale agent-based tumor model: simulating gene-protein interaction profiles, cell phenotypes and multicellular patterns in brain cancer. J Theor Biol 244: 96-107.